Skip to main content
Top
Published in: Supportive Care in Cancer 6/2018

Open Access 01-06-2018 | Review Article

A systematic review of the measurement properties of the Body Image Scale (BIS) in cancer patients

Authors: Heleen C. Melissant, Koen I. Neijenhuijs, Femke Jansen, Neil K. Aaronson, Mogens Groenvold, Bernhard Holzner, Caroline B. Terwee, Cornelia F. van Uden-Kraan, Pim Cuijpers, Irma M. Verdonck-de Leeuw

Published in: Supportive Care in Cancer | Issue 6/2018

Login to get access

Abstract

Introduction

Body image is acknowledged as an important aspect of health-related quality of life in cancer patients. The Body Image Scale (BIS) is a patient-reported outcome measure (PROM) to evaluate body image in cancer patients. The aim of this study was to systematically review measurement properties of the BIS among cancer patients.

Methods

A search in Embase, MEDLINE, PsycINFO, and Web of Science was performed to identify studies that investigated measurement properties of the BIS (Prospero ID 42017057237). Study quality was assessed (excellent, good, fair, poor), and data were extracted and analyzed according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology on structural validity, internal consistency, reliability, measurement error, hypothesis testing for construct validity, and responsiveness. Evidence was categorized into sufficient, insufficient, inconsistent, or indeterminate.

Results

Nine studies were included. Evidence was sufficient for structural validity (one factor solution), internal consistency (α = 0.86–0.96), and reliability (r > 0.70); indeterminate for measurement error (information on minimal important change lacked) and responsiveness (increasing body image disturbance in only one study); and inconsistent for hypothesis testing (conflicting results). Quality of the evidence was moderate to low. No studies reported on cross-cultural validity.

Conclusion

The BIS is a PROM with good structural validity, internal consistency, and test-retest reliability, but good quality studies on the other measurement properties are needed to optimize evidence. It is recommended to include a wider variety of cancer diagnoses and treatment modalities in these future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cash TF, Smolak L (2011) Body image: a handbook of science, practice, and prevention, 2nd edn. Guilford Press, New York Cash TF, Smolak L (2011) Body image: a handbook of science, practice, and prevention, 2nd edn. Guilford Press, New York
9.
go back to reference Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32:1480–1501. https://doi.org/10.1200/JCO.2013.53.5948 CrossRefPubMed Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32:1480–1501. https://​doi.​org/​10.​1200/​JCO.​2013.​53.​5948 CrossRefPubMed
23.
go back to reference van der Hout A, van Uden-Kraan CF, Witte BI, Coupé VMH, Leemans CR, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM (2017) Efficacy, cost-utility and reach of an eHealth self-management application “Oncokompas” that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial. Trials 18:228. https://doi.org/10.1186/s13063-017-1952-1 CrossRefPubMedPubMedCentral van der Hout A, van Uden-Kraan CF, Witte BI, Coupé VMH, Leemans CR, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM (2017) Efficacy, cost-utility and reach of an eHealth self-management application “Oncokompas” that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial. Trials 18:228. https://​doi.​org/​10.​1186/​s13063-017-1952-1 CrossRefPubMedPubMedCentral
25.
34.
go back to reference Al-Ghazal SK, Fallowfield L, Blamey RW (2000) Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 36:1938–1943CrossRefPubMed Al-Ghazal SK, Fallowfield L, Blamey RW (2000) Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 36:1938–1943CrossRefPubMed
37.
go back to reference Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, Goddard A (1992) Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients’ ratings, observers’ ratings and objective assessments. Radiother Oncol 25:153–159CrossRefPubMed Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, Goddard A (1992) Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients’ ratings, observers’ ratings and objective assessments. Radiother Oncol 25:153–159CrossRefPubMed
42.
go back to reference Terwee CB, Prinsen CA, Chiarotto A, Westerman MJ, de Vet HC, Patrick D, Alonso J, Bouter LM, Mokkink LB (2016) Consensus-based standards and criteria for evaluating the content validity of patient-reported outcome measures: a COSMIN Delphi study. Qual Life Res 25:1–1CrossRef Terwee CB, Prinsen CA, Chiarotto A, Westerman MJ, de Vet HC, Patrick D, Alonso J, Bouter LM, Mokkink LB (2016) Consensus-based standards and criteria for evaluating the content validity of patient-reported outcome measures: a COSMIN Delphi study. Qual Life Res 25:1–1CrossRef
Metadata
Title
A systematic review of the measurement properties of the Body Image Scale (BIS) in cancer patients
Authors
Heleen C. Melissant
Koen I. Neijenhuijs
Femke Jansen
Neil K. Aaronson
Mogens Groenvold
Bernhard Holzner
Caroline B. Terwee
Cornelia F. van Uden-Kraan
Pim Cuijpers
Irma M. Verdonck-de Leeuw
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4145-x

Other articles of this Issue 6/2018

Supportive Care in Cancer 6/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine